Joint with: Decoding HIV Persistence: Strategies for Curing HIV Infection
HIV Vaccines: Intersections of Basic and Clinical Science
Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Penny L. Moore, Marit van Gils and Kevin O. Saunders
In Person
On Demand
Apr 16–19, 2026 | Beaver Run Conference Center, Breckenridge, CO, United States
Scientific Organizers:
Penny L. Moore, Marit van Gils and Kevin O. Saunders
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Thursday, April 16, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Friday, April 17, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address (Joint)
8:00–9:00 AM
Alexandra Trkola †, University of Zürich
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
HIV Vaccines: Learning from the Swiss X-BNAb Cohort for Prevention and Cure
Immune Interventions Interfacing HIV Prevention and Cure (Joint)
9:00–11:15 AM
Drew Weissman †, University of Pennsylvania
mRNA-Based Approaches for Manipulating HIV Reservoirs and Immune Responses
mRNA-Based Approaches for Manipulating HIV Reservoirs and Immune Responses
Devi SenGupta †, Gilead Sciences, Inc.
Long-acting ART in HIV Prevention and Cure
Long-acting ART in HIV Prevention and Cure
Leonidas Stamatatos †, Fred Hutchinson Cancer Research Center
Vaccination of PLWH, using 426C Derived Immunogens
Vaccination of PLWH, using 426C Derived Immunogens
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Coffee Available
4:30–5:00 PM
Keeping up with the Changing HIV Envelope
5:00–7:00 PM
Penny L. Moore, University of the Witwatersrand and National Institute for Communicable Diseases
African bNAb Immunogens
African bNAb Immunogens
Margaret E. Ackerman †, Dartmouth College
Fc Effector Function in HIV Infection and Vaccination
Fc Effector Function in HIV Infection and Vaccination
Aime Marcel Simon Tongo Passo †, Center for Study of Emerging and Re-Emerging Diseases
Viral Diversity in Central Africa: Known and Unknowns
Viral Diversity in Central Africa: Known and Unknowns
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Saturday, April 18, 2026
Breakfast
7:00–8:00 AM
The Vaccine Pipeline: Integrating Basic and Clinical Insights
8:00–11:00 AM
Gabriel D. Victora †, Rockefeller University
Germinal Centre Dynamics
Germinal Centre Dynamics
Richard T. Wyatt †, The Scripps Research Institute
Triggering bNAbs in Non-Human Primates
Triggering bNAbs in Non-Human Primates
Persephone Borrow †, University of Oxford
Systems Immunology of HIV bnAb Induction; / Ag Presentation by mRNA-LNP
Systems Immunology of HIV bnAb Induction; / Ag Presentation by mRNA-LNP
Louis J. Picker †, Oregon Health & Science University
Progress in CMV based Vaccines
Progress in CMV based Vaccines
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Targeting the Needle in the Haystack: Clinical Trials of Germline Targeting Immunogens
5:00–7:00 PM
Kevin O. Saunders, Duke University
Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309
Induction of HCDR3-Binding and CD4 Mimicking Antibodies in HVTN300 and HVTN309
Eunice Wambui Nduati †, KEMRI, Wellcome Trust
Germline Targeting Immunogens and Precursors in African Populations
Germline Targeting Immunogens and Precursors in African Populations
Marit van Gils, Amsterdam UMC
Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110
Germline Targeting Immunogens in Human Clinical Trials; C101, C107, C110
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Sunday, April 19, 2026
Breakfast
7:00–8:00 AM
Looking to the Future: New Tools, Platforms and Delivery Systems
8:00–11:00 AM
Eric A. Appel †, Stanford University
Injectable Hydrogels for the Ultra-Long-Term Stabilization and Delivery of Vaccines
Injectable Hydrogels for the Ultra-Long-Term Stabilization and Delivery of Vaccines
Shannon Miller †, Inimmune Corporation
Adjuvants for Mucosal Targeting
Adjuvants for Mucosal Targeting
Robert L. Garcea †, University of Colorado Boulder
Atomic Layer Deposition-Based Coatings for HIV Vaccine Applications
Atomic Layer Deposition-Based Coatings for HIV Vaccine Applications
Rory Henderson †, Duke University
Large Language Models to Identify bnAbs and Design Vaccines to Them
Large Language Models to Identify bnAbs and Design Vaccines to Them
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Coffee Available
4:30–5:00 PM
B Cell Responses and Broadly-Neutralizing Antibodies: Trials and Tribulations (Joint)
5:00–6:45 PM
Marina F. Caskey, Rockefeller University
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Combined Immunotherapy with IL-15 Agonists and Broadly-Neutralizing Antibodies
Paula M Cannon †, University of Southern California, Keck School of Medicine
In vivo B Cell Engineering
In vivo B Cell Engineering
William Schief †, The Scripps Research and IAVI
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Combining Germline Targeting Approaches Across Diverse bNAb Epitopes
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Monday, April 20, 2026
Departure
12:00–11:59 PM
Subscribe for Updates